Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Leaf

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
American Journal of Respiratory and Critical Care Medicine|November 15, 2014
Reply: active and native vitamin D in critical illnessDavid E Leaf, Anas Raed, Michael W Donnino, et al.
STAR Protocols|November 17, 2021
Protocol to assess performance of crisis standards of care guidelines for clinical triageLouis T Merriam, Maheetha Bharadwaj, Julia L Jezmir, et al.
Critical Care (London, England)|April 19, 2015
Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patientsDavid E Leaf, Heather E Croy, Sara J Abrahams, et al.
Clinical Endocrinology|February 19, 2013
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomesDavid E Leaf, Sushrut S Waikar, Myles Wolf, et al.
Obesity (Silver Spring, Md.)|June 10, 2021
Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the USAllon N Friedman, John Guirguis, Rajat Kapoor, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2012
FGF-23 levels in patients with AKI and risk of adverse outcomesDavid E Leaf, Myles Wolf, Sushrut S Waikar, et al.
Journal of General Internal Medicine|October 27, 2019
High Prevalence of Imposterism Among Female Harvard Medical and Dental StudentsAlison M Holliday, Galina Gheihman, Cynthia Cooper, et al.
Critical Care Explorations|September 2, 2022
Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19Ashwin Sunderraj, Chloe Cho, Xuan Cai, et al.
Critical Care (London, England)|December 4, 2023
Iron as an emerging therapeutic target in critically ill patientsCoralie Grange, François Lux, Thomas Brichart, et al.
BMC Nephrology|February 2, 2017
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case seriesFrank B Cortazar, David E Leaf, Charles T Owens, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
American Journal of Respiratory and Critical Care Medicine|November 15, 2014
Reply: active and native vitamin D in critical illnessDavid E Leaf, Anas Raed, Michael W Donnino, et al.
STAR Protocols|November 17, 2021
Protocol to assess performance of crisis standards of care guidelines for clinical triageLouis T Merriam, Maheetha Bharadwaj, Julia L Jezmir, et al.
Critical Care (London, England)|April 19, 2015
Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patientsDavid E Leaf, Heather E Croy, Sara J Abrahams, et al.
Clinical Endocrinology|February 19, 2013
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomesDavid E Leaf, Sushrut S Waikar, Myles Wolf, et al.
Obesity (Silver Spring, Md.)|June 10, 2021
Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the USAllon N Friedman, John Guirguis, Rajat Kapoor, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2012
FGF-23 levels in patients with AKI and risk of adverse outcomesDavid E Leaf, Myles Wolf, Sushrut S Waikar, et al.
Journal of General Internal Medicine|October 27, 2019
High Prevalence of Imposterism Among Female Harvard Medical and Dental StudentsAlison M Holliday, Galina Gheihman, Cynthia Cooper, et al.
Critical Care Explorations|September 2, 2022
Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19Ashwin Sunderraj, Chloe Cho, Xuan Cai, et al.
Critical Care (London, England)|December 4, 2023
Iron as an emerging therapeutic target in critically ill patientsCoralie Grange, François Lux, Thomas Brichart, et al.
BMC Nephrology|February 2, 2017
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case seriesFrank B Cortazar, David E Leaf, Charles T Owens, et al.
Pageof 17